Telehealth company Hims on Tuesday agreed to acquire ZAVA, expanding its operations to Germany, France and Ireland as it contends with U.S. GLP-1 volatility.
Why it matters: Hims would benefit from European stability in the GLP-1 category and gain an advantage over exclusively U.S.-operating rival Ro.
